Curious on how we modified blood vessels to boost immunity and treat brain cancer? 💉🧠 Our new publication is out now on @Cancer_Cell ! Big congrats to the first authors of this work, @mohanraj9706 , @AleVaccaro93 & @tiarnevdw , and to the whole team 🥳 https://t.co/KRgJq3Lo2R
Excited to share our recent study on immune cell proteomes in liver cancer, now published in @CellGenomics.
https://t.co/IVZTvQqMwn
Proteomics data are now publicly accessible at https://t.co/mkWgulsyeb
A thread about our findings on T cells and macrophages in tumors (1/6)
Metabolic modulation of tumors with engineered bacteria for immunotherapy. Local production of L-arginine by a tumor-colonizing E. coli strain increases anti-tumor T cell responses. #NBThighlight by the @RGeigerlab
https://t.co/zbByOouoRN
Huge congrats to my friend and colleague @CanleFer and all the co-authors on the publication of this remarkable work! Very happy to be part of such a vibrant and exciting environment @RGeigerlab@BellinzonaIrb
Excited to share our latest publication in @Nature. Colonization of tumors with probiotic bacteria - engineered to synthesize L-arginine - synergize with immunotherapy.
Great collaboration with @synlogic_tx, @jose_m_lora and @sallustolab.
A thread (1/6)
https://t.co/J70wUyLSrB